These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15570169)

  • 1. Angiotensin receptor gene expression in candesartan mediated neuroprotection.
    Lu Q; Zhu YZ; Wong PT
    Neuroreport; 2004 Dec; 15(17):2643-6. PubMed ID: 15570169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.
    Zorad S; Dou JT; Benicky J; Hutanu D; Tybitanclova K; Zhou J; Saavedra JM
    Eur J Pharmacol; 2006 Dec; 552(1-3):112-22. PubMed ID: 17064684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats.
    Lu Q; Zhu YZ; Wong PT
    Neuroreport; 2005 Nov; 16(17):1963-7. PubMed ID: 16272888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II type 1 receptor blockade prevents up-regulation of angiotensin II type 1A receptors in rat injured artery.
    Tazawa S; Nakane T; Chiba S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):898-904. PubMed ID: 9918604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress.
    Hamai M; Iwai M; Ide A; Tomochika H; Tomono Y; Mogi M; Horiuchi M
    Neuropharmacology; 2006 Sep; 51(4):822-8. PubMed ID: 16824557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist.
    Otsuka M; Takahashi H; Shiratori M; Chiba H; Abe S
    Thorax; 2004 Jan; 59(1):31-8. PubMed ID: 14694243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats.
    Inscho EW; Imig JD; Deichmann PC; Cook AK
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S178-83. PubMed ID: 9892160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure.
    Bernardi S; Candido R; Toffoli B; Carretta R; Fabris B
    Nephrol Dial Transplant; 2011 Mar; 26(3):832-8. PubMed ID: 20810455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats.
    Nishiyama A; Yoshizumi M; Rahman M; Kobori H; Seth DM; Miyatake A; Zhang GX; Yao L; Hitomi H; Shokoji T; Kiyomoto H; Kimura S; Tamaki T; Kohno M; Abe Y
    Kidney Int; 2004 Mar; 65(3):972-81. PubMed ID: 14871417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats.
    Engelhorn T; Doerfler A; Heusch G; Schulz R
    Neurosci Lett; 2006 Oct; 406(1-2):92-6. PubMed ID: 16901636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure.
    Noda M; Matsuo T; Fukuda R; Ohta M; Nagano H; Shibouta Y; Naka T; Nishikawa K; Imura Y
    Kidney Int; 1999 Sep; 56(3):898-909. PubMed ID: 10469358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
    Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
    J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats.
    Omura-Matsuoka E; Yagita Y; Sasaki T; Terasaki Y; Oyama N; Sugiyama Y; Okazaki S; Sakoda S; Kitagawa K
    Hypertens Res; 2009 Jul; 32(7):548-53. PubMed ID: 19424281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease.
    van de Wal RM; van der Harst P; Wagenaar LJ; Wassmann S; Morshuis WJ; Nickenig G; Buikema H; Plokker HW; van Veldhuisen DJ; van Gilst WH; Voors AA
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):372-9. PubMed ID: 18049304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
    Jones ES; Black MJ; Widdop RE
    J Mol Cell Cardiol; 2004 Nov; 37(5):1023-30. PubMed ID: 15522279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative effect of angiotensin AT(1) and endothelin ET(A) receptor antagonism limits the brain damage after ischemic stroke in rat.
    Stenman E; Jamali R; Henriksson M; Maddahi A; Edvinsson L
    Eur J Pharmacol; 2007 Sep; 570(1-3):142-8. PubMed ID: 17597600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
    Singh N; Sharma G; Singh N; Hanif K
    Int J Stroke; 2014 Jul; 9(5):560-8. PubMed ID: 23013350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with angiotensin II type 1 receptor antagonist suppresses glomerular activator protein-1 activity in salt-sensitive hypertensive rats.
    Otsuka F; Ogura T; Yamauchi T; Sato M; Kataoka H; Kageyama J; Makino H
    Kidney Blood Press Res; 2000; 23(1):35-41. PubMed ID: 10567852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin II AT1 receptor inhibition and exercise training on insulin action in rats on high-fat diet.
    Wang Z; Koike T; Li P; Jiang H; Natsume Y; Mu L; Chen T; Oshida Y
    Life Sci; 2012 Feb; 90(9-10):322-7. PubMed ID: 22210187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.